Annual ROA
-43.14%
-4.56%-11.82%
31 December 2023
Summary:
Silence Therapeutics annual return on assets is currently -43.14%, with the most recent change of -4.56% (-11.82%) on 31 December 2023. During the last 3 years, it has risen by +3.91% (+8.31%). SLN annual ROA is now -1377.40% below its all-time high of -2.92%, reached on 31 December 2017.SLN ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-39.52%
-9.54%-31.82%
01 September 2024
Summary:
Silence Therapeutics quarterly return on assets is currently -39.52%, with the most recent change of -9.54% (-31.82%) on 01 September 2024. Over the past year, it has increased by +2.33% (+5.57%). SLN quarterly ROA is now -209.23% below its all-time high of -12.78%, reached on 30 September 2020.SLN Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.8% | +5.6% |
3 y3 years | +8.3% | +13.4% |
5 y5 years | -8.6% | - |
SLN ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -11.8% | +8.3% | -31.8% | +13.4% |
5 y | 5 years | -11.8% | +8.3% | -209.2% | +13.4% |
alltime | all time | -1377.4% | +59.0% | -209.2% | +13.4% |
Silence Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -39.52%(+31.8%) |
June 2024 | - | -29.98%(-1.5%) |
Mar 2024 | - | -30.45%(-31.7%) |
Dec 2023 | -43.14%(+11.8%) | -44.59%(+6.5%) |
Sept 2023 | - | -41.85%(+1.1%) |
June 2023 | - | -41.39%(-4.3%) |
Mar 2023 | - | -43.25%(+6.4%) |
Dec 2022 | -38.58%(-12.1%) | -40.63%(+6.5%) |
Sept 2022 | - | -38.15%(-10.2%) |
June 2022 | - | -42.47%(+1.8%) |
Mar 2022 | - | -41.73%(-1.8%) |
Dec 2021 | -43.90%(-6.7%) | -42.48%(-6.9%) |
Sept 2021 | - | -45.63%(+4.5%) |
June 2021 | - | -43.66%(+32.0%) |
Mar 2021 | - | -33.08%(+41.2%) |
Dec 2020 | -47.05%(+3.3%) | -23.42%(+83.3%) |
Sept 2020 | - | -12.78% |
Dec 2019 | -45.56%(+14.7%) | - |
Dec 2018 | -39.72%(+1260.3%) | - |
Dec 2017 | -2.92%(-79.6%) | - |
Dec 2016 | -14.32%(-3.0%) | - |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | -14.77%(-61.8%) | - |
Dec 2014 | -38.62%(+4.1%) | - |
Dec 2013 | -37.11%(-64.8%) | - |
Dec 2012 | -105.29%(+494.9%) | - |
Dec 2011 | -17.70%(-54.2%) | - |
Dec 2010 | -38.64%(-35.9%) | - |
Dec 2009 | -60.26%(+30.9%) | - |
Dec 2008 | -46.03%(+60.9%) | - |
Dec 2007 | -28.60%(+26.4%) | - |
Dec 2006 | -22.63%(-38.2%) | - |
Dec 2005 | -36.59%(-40.1%) | - |
Dec 2004 | -61.13%(+107.3%) | - |
Dec 2003 | -29.49%(+83.2%) | - |
Dec 2002 | -16.10%(-18.4%) | - |
Dec 2001 | -19.72%(+18.9%) | - |
Dec 2000 | -16.59%(-42.5%) | - |
Dec 1999 | -28.86%(-28.0%) | - |
Dec 1998 | -40.09%(+21.4%) | - |
Dec 1997 | -33.03%(+153.5%) | - |
Dec 1996 | -13.03%(-55.1%) | - |
Dec 1995 | -29.04% | - |
FAQ
- What is Silence Therapeutics annual return on assets?
- What is the all time high annual ROA for Silence Therapeutics?
- What is Silence Therapeutics annual ROA year-on-year change?
- What is Silence Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Silence Therapeutics?
- What is Silence Therapeutics quarterly ROA year-on-year change?
What is Silence Therapeutics annual return on assets?
The current annual ROA of SLN is -43.14%
What is the all time high annual ROA for Silence Therapeutics?
Silence Therapeutics all-time high annual return on assets is -2.92%
What is Silence Therapeutics annual ROA year-on-year change?
Over the past year, SLN annual return on assets has changed by -4.56% (-11.82%)
What is Silence Therapeutics quarterly return on assets?
The current quarterly ROA of SLN is -39.52%
What is the all time high quarterly ROA for Silence Therapeutics?
Silence Therapeutics all-time high quarterly return on assets is -12.78%
What is Silence Therapeutics quarterly ROA year-on-year change?
Over the past year, SLN quarterly return on assets has changed by +2.33% (+5.57%)